65
Views
4
CrossRef citations to date
0
Altmetric
Clinical Interventions to Address Methamphetamine Use

A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 326-333 | Received 27 Jul 2007, Accepted 10 Jan 2008, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Edna Soares & Frederico C. Pereira. (2019) Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups. Expert Opinion on Pharmacotherapy 20:18, pages 2273-2293.
Read now
Tracy L. Hellem, Young-Hoon Sung, Xian-Feng Shi, Marjorie A. Pett, Gwen Latendresse, Jubel Morgan, Rebekah S. Huber, Danielle Kuykendall, Kelly J. Lundberg & Perry F. Renshaw. (2015) Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study. Journal of Dual Diagnosis 11:3-4, pages 189-202.
Read now
Maryam Afshar, Clifford M. Knapp, Ofra Sarid-Segal, Eric Devine, Laurie Sickles Colaneri, Lisa Tozier, Megan E. Waters, Megan A. Putnam & Domenic A. Ciraulo. (2012) The Efficacy of Mirtazapine in the Treatment of Cocaine Dependence with Comorbid Depression. The American Journal of Drug and Alcohol Abuse 38:2, pages 181-186.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.